{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:03:24Z","timestamp":1791824604553,"version":"4.3.4"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.phymed.2025.157707","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T07:58:32Z","timestamp":1765526312000},"page":"157707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Xuesaitong injection for acute cerebral infarction: Efficacy and safety meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"150","author":[{"given":"Yunzi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyan","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6295-8220","authenticated-orcid":false,"given":"Xiaodong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1617-6110","authenticated-orcid":false,"given":"Jiarui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"06","key":"10.1016\/j.phymed.2025.157707_bib0001","first-page":"59","article-title":"Improvement effect of Xuesaitong injection on degree of neurological deficit in patients with cerebral infarction","volume":"7","author":"Chen","year":"2022","journal-title":"Clinical Res. Pract."},{"issue":"11","key":"10.1016\/j.phymed.2025.157707_bib0002","first-page":"1365","article-title":"Impact of Xuesaitong injection combined with Troxerutin on coagulation function and neurological function in patients with acute cerebral infarction","volume":"31","author":"Ding","year":"2024","journal-title":"Clinical. Med. Eng."},{"issue":"02","key":"10.1016\/j.phymed.2025.157707_bib0003","article-title":"Effect of Atorvastatin calcium dispersible tablet combined with Xuesaitong injection on blood lipid, hemorheology and neurological function in patients with acute cerebral infarction","volume":"40","author":"Fu","year":"2018","journal-title":"Hebei J. Traditional Chin. Med."},{"issue":"19","key":"10.1016\/j.phymed.2025.157707_bib0004","first-page":"79","article-title":"A clinical study on the treatment of acute cerebral infarction with Xuesaitong and Ozagrel sodium","volume":"1","author":"Gao","year":"2011","journal-title":"J. Front. Med."},{"issue":"26","key":"10.1016\/j.phymed.2025.157707_bib0008","first-page":"12","article-title":"Effects and mechanism of Xuesaitong Injection on expressions of VEGF pathway in mice brain microvascular endothelial cells after OGD\/R","volume":"18","author":"Guo","year":"2021","journal-title":"Chin. Med. Herald."},{"issue":"03","key":"10.1016\/j.phymed.2025.157707_bib0007","first-page":"372","article-title":"A study on the value of Xuesaitong in promoting recanalization in elderly patients with acute cerebral infarction and its regulatory effect on the nervous system","volume":"47","author":"Guo","year":"2023","journal-title":"Guizhou Med. J."},{"issue":"19","key":"10.1016\/j.phymed.2025.157707_bib0005","first-page":"84","article-title":"The efficacy of Xuesaitong combined with western medicine antiplatelet therapy in patients with cerebral infarction and its impact on lipid metabolism","volume":"19","author":"Guo","year":"2016","journal-title":"Chin. J. Pract Nerv Dis."},{"issue":"08","key":"10.1016\/j.phymed.2025.157707_bib0006","first-page":"108","article-title":"An observational study on the efficacy of Ozagrel sodium combined with Xuesaitong injection in the treatment of acute cerebral infarction","volume":"31","author":"Guo","year":"2019","journal-title":"Med. J. Chin. People's Health."},{"issue":"05","key":"10.1016\/j.phymed.2025.157707_bib0010","article-title":"Clinical effect of butylphthalide combined with Xuesaitong in the treatment of acute ischemic stroke","volume":"47","author":"He","year":"2023","journal-title":"Heilongjiang Med. J."},{"issue":"03","key":"10.1016\/j.phymed.2025.157707_bib0009","first-page":"571","article-title":"The effect of Xuesaitong combined with Dinephtal on serum levels of PAF, GFAP, and MCP-1 in patients with acute cerebral infarction","volume":"34","author":"He","year":"2021","journal-title":"Heilongjiang Med. J."},{"key":"10.1016\/j.phymed.2025.157707_bib0012","first-page":"104","article-title":"Influence of Xue Sai Tong on the serum VEGF and VEGFR expression at different time points of acute cerebralinfarction","volume":"11","author":"Huang","year":"2015","journal-title":"Chin. Commu Doc"},{"issue":"15","key":"10.1016\/j.phymed.2025.157707_bib0011","first-page":"138","article-title":"Observed the treatment effect of Xuesetong combined with Edaravone in treatment cerebral infarction","volume":"7","author":"Huang","year":"2016","journal-title":"Chin. Health Stand Manag."},{"issue":"07","key":"10.1016\/j.phymed.2025.157707_bib0013","first-page":"1547","article-title":"Efficacy of intravenous alteplase thrombolysis in treating elderly patients with acute cerebral infarction and its risk factors","volume":"45","author":"Ji","year":"2025","journal-title":"Chin J. Gerontol."},{"issue":"10","key":"10.1016\/j.phymed.2025.157707_bib0014","first-page":"65","article-title":"Clinical effect of Xue Saitong injection in the adjunctive treatment of acute cerebral infarction","volume":"17","author":"Jiang","year":"2024","journal-title":"Chin. J. Clinical Ration Drug Use."},{"issue":"23","key":"10.1016\/j.phymed.2025.157707_bib0015","first-page":"158","article-title":"A preliminary analysis of the clinical efficacy of Xuesaitong combined with Edaravone in the treatment of cerebral infarction","volume":"11","author":"Li","year":"2016","journal-title":"Chin. Pract. Med."},{"issue":"30","key":"10.1016\/j.phymed.2025.157707_bib0019","first-page":"48","article-title":"Efficacy of Xuesaitong injection combined with Alteplase injection in the treatment of acute cerebral infarction and its impact on inflammatory factors","volume":"16","author":"Li","year":"2023","journal-title":"Chin. J. Clinical Ration Drug Use."},{"issue":"32","key":"10.1016\/j.phymed.2025.157707_bib0016","article-title":"Effectiveness comparisons of different Chinese herbal injection therapies for acute cerebral infarction: a protocol for systematic review and network meta-analysis","volume":"99","author":"Li","year":"2020","journal-title":"Medicine (Baltimore). 7"},{"issue":"10","key":"10.1016\/j.phymed.2025.157707_bib0017","first-page":"64","article-title":"Research progress on risk prediction of hemorrhagic transformation in acute ischemic stroke after intravenous thrombolysis. Chin","volume":"30","author":"Li","year":"2023","journal-title":"Mod. Med."},{"key":"10.1016\/j.phymed.2025.157707_bib0018","article-title":"Global, regional, and national burden of ischemic stroke, 1990-2021: an analysis of data from the global burden of disease study 2021","volume":"75","author":"Li","year":"2024","journal-title":"EClin. Med."},{"issue":"01","key":"10.1016\/j.phymed.2025.157707_bib0020","first-page":"20","article-title":"Network meta-analysis of traditional Chinese medicine injection combined with Edaravone in treatment of senile cerebral infarction","volume":"46","author":"Lin","year":"2025","journal-title":"J. Qiqihar Med Univ."},{"issue":"2","key":"10.1016\/j.phymed.2025.157707_bib0021","first-page":"217","article-title":"Effect of Xuesaitong injection on PSD-95 and syp protein expression in cortex of focal cerebral infarction rats","volume":"12","author":"Liu","year":"2014","journal-title":"Chin J. Integr Med. Cardio-Cerebrovasc Dis."},{"issue":"08","key":"10.1016\/j.phymed.2025.157707_bib0025","first-page":"213","article-title":"Effect of Xuesetong combined with Alteplase on acute cerebral infarction and Effect on serum levels of ET-1and TXA2","volume":"40","author":"Liu","year":"2022","journal-title":"Chin. Arch. Traditional Chin Med."},{"issue":"27","key":"10.1016\/j.phymed.2025.157707_bib0022","first-page":"101","article-title":"Analysis of medication rules in traditional Chinese medicine combined with thrombolytic therapy in the treatment of acute cere bral infarction based on data mining","volume":"21","author":"Liu","year":"2024","journal-title":"Chin. Med. Her."},{"issue":"23","key":"10.1016\/j.phymed.2025.157707_bib0024","first-page":"169","article-title":"An exploration of the efficacy of XueSaitong injection and diltiazem hydrochloride in the treatment of acute cerebral infarction","volume":"32","author":"Liu","year":"2011","journal-title":"J. Med Forum."},{"issue":"12","key":"10.1016\/j.phymed.2025.157707_bib0023","first-page":"73","article-title":"Analysis of the effects of atorvastatin calcium combined with Xuesaitong injection on hemorheological parameters and neurological function in patients with diabetes complicated by cerebral infarction","volume":"22","author":"Liu","year":"2019","journal-title":"Diabetes New World"},{"issue":"24","key":"10.1016\/j.phymed.2025.157707_bib0026","first-page":"119","article-title":"A clinical observation of 56 cases of acute cerebral infarction treated with Xuesaitong injection","volume":"21","author":"Lv","year":"2015","journal-title":"Psychol Doc"},{"issue":"11","key":"10.1016\/j.phymed.2025.157707_bib0027","first-page":"58","article-title":"Research progress in traditional Chinese medicine for the secondary prevention of ischemic stroke","volume":"46","author":"Men","year":"2024","journal-title":"Hubei J. Traditional Chin. Med."},{"key":"10.1016\/j.phymed.2025.157707_bib0028","unstructured":"National Health Commission of the PRC., 2024, Guidelines for the prevention and treatment of cerebrovascular diseases (2024 Edition) https:\/\/www.nhc.gov.cn\/cms-search\/downFiles\/8b6cbb73fb2d49c2bab32f5f3325fafa.pdf."},{"issue":"05","key":"10.1016\/j.phymed.2025.157707_bib0029","first-page":"52","article-title":"Clinical effect of Xuesaitong injection combined with edaravone on patients with acute cerebral infarction","volume":"51","author":"Ouyang","year":"2022","journal-title":"Heilongjiang J. Traditional Chin. Med."},{"issue":"01","key":"10.1016\/j.phymed.2025.157707_bib0030","first-page":"82","article-title":"Effect of butylphthalide and sodium chloride injection on the clinical efficacy of patients with cerebral infarction","volume":"48","author":"Pei","year":"2025","journal-title":"J. Med Sci Yanbian Univ."},{"issue":"27","key":"10.1016\/j.phymed.2025.157707_bib0031","first-page":"28","article-title":"Effect of Xuesaitong injection combined with butylphthalide in the treatment of acute cerebral infarction and its influence on neurological function of patients","volume":"7","author":"Ping","year":"2022","journal-title":"Clinical Res. Pract."},{"issue":"03","key":"10.1016\/j.phymed.2025.157707_bib0032","first-page":"51","article-title":"Effect of Xuesaitong on vascular endothelial growth factor in the treatment of cerebral infarction","volume":"12","author":"Shen","year":"2009","journal-title":"Chin. J. Pract Nerv Dis."},{"issue":"08","key":"10.1016\/j.phymed.2025.157707_bib0033","first-page":"2059","article-title":"Overview of the chemical composition and pharmacological effects of Panax Notoginseng and prediction of quality markers","volume":"48","author":"Shi","year":"2023","journal-title":"Chin J. Chin Mater Med."},{"issue":"05","key":"10.1016\/j.phymed.2025.157707_bib0034","first-page":"40","article-title":"Efficacy of Xue Saitong in the treatment of 80 cases of acute cerebral infarction","volume":"28","author":"Song","year":"2013","journal-title":"Chin. J. Urban. Rural Enterp Hyg."},{"issue":"08","key":"10.1016\/j.phymed.2025.157707_bib0036","first-page":"18","article-title":"Meta-analysis on clinical efficacy of Combined Xuesaitong versus Western Medicine in the treatment of cerebral infarction","volume":"41","author":"Sun","year":"2020","journal-title":"J. Kunming Med Univ."},{"issue":"01","key":"10.1016\/j.phymed.2025.157707_bib0035","first-page":"71","article-title":"Study on the effect of Xuesaitong injection treatment on platelet parameters and hemorheological status in 336 cases of ischemic cerebral infarction","volume":"16","author":"Sun","year":"2019","journal-title":"J. North Pharm."},{"issue":"13","key":"10.1016\/j.phymed.2025.157707_bib0037","first-page":"179","article-title":"Current status of drug treatment for acute cerebral infarction","volume":"11","author":"Tang","year":"2018","journal-title":"Chin. J. Clinical Ration Drug Use."},{"issue":"04","key":"10.1016\/j.phymed.2025.157707_bib0038","first-page":"16","article-title":"Clinical effect of Xuesaitong combined with Nerve Growth Factor peptide in the treatment of acute cerebral infarction","volume":"24","author":"Tong","year":"2024","journal-title":"Pract Clinical J. Integr Traditional Chin. Western Med."},{"issue":"06","key":"10.1016\/j.phymed.2025.157707_bib0044","first-page":"1292","article-title":"Efficacy of rhTNK-tPA combined with edaravone dexpresanol in the treatment of acute cerebral infarction in the elderly","volume":"45","author":"Wang","year":"2025","journal-title":"Chin J. Geron."},{"issue":"03","key":"10.1016\/j.phymed.2025.157707_bib0043","first-page":"142","article-title":"Observation of 24 cases of acute cerebral infarction treated with Western medicine combined with Xuesaitong","author":"Wang","year":"2004","journal-title":"J. Pract Traditional Chin Med."},{"issue":"04","key":"10.1016\/j.phymed.2025.157707_bib0040","first-page":"639","article-title":"Efficacy of Xuesaitong injection in the treatment of acute cerebral infarction and its impact on high-sensitivity C-reactive protein","volume":"20","author":"Wang","year":"2011","journal-title":"J. Emerg. Traditional. Chin. Med."},{"issue":"12","key":"10.1016\/j.phymed.2025.157707_bib0041","first-page":"1883","article-title":"Progress and prospect of intra-arterial thrombolytic therapy for acute cerebral infarction","volume":"53","author":"Wang","year":"2024","journal-title":"Chongqing Med. J."},{"issue":"3","key":"10.1016\/j.phymed.2025.157707_bib0039","first-page":"160","article-title":"Current application of traditional Chinese medicine in disease management for patients with cerebral infarction","volume":"33","author":"Wang","year":"2025","journal-title":"J. Traditional Chin. Med. Manag."},{"key":"10.1016\/j.phymed.2025.157707_bib0042","first-page":"1","article-title":"Traditional Chinese medicine in treatment of ischemic stroke by regulating BDNF\/TrkB signaling pathway: a review","author":"Wang","year":"2025","journal-title":"Chin J. Exp. Traditional Med Formulae."},{"issue":"09","key":"10.1016\/j.phymed.2025.157707_bib0045","first-page":"194","article-title":"Research progress on traditional Chinese medicine intervention in the acute and convalescent phases of cerebral infarction","volume":"21","author":"Xiang","year":"2024","journal-title":"J. North Pharm."},{"issue":"02","key":"10.1016\/j.phymed.2025.157707_bib0046","first-page":"175","article-title":"Research progress on risk factors related to neurological deterioration in the early stage of acute cerebral infarction","volume":"19","author":"Xie","year":"2024","journal-title":"Intern. Med."},{"issue":"02","key":"10.1016\/j.phymed.2025.157707_bib0047","first-page":"286","article-title":"Association of serum inflammatory factors with neurological deficit in patients with acute cerebral infarction","volume":"46","author":"Xv","year":"2025","journal-title":"Jilin Med J"},{"issue":"22","key":"10.1016\/j.phymed.2025.157707_bib0048","first-page":"121","article-title":"To observe the effect of Xuesaitong combined with Alprostadil in the treatment of patients with cerebral infarction","volume":"19","author":"Xv","year":"2021","journal-title":"Guide of Chin Med"},{"issue":"15","key":"10.1016\/j.phymed.2025.157707_bib0049","first-page":"3649","article-title":"Effect of aniracetam combined with Xuesaitong on cerebral blood flow and serum TLR4\/NF-\u03bab signaling pathway in elderly patients with acute cerebral infarction","volume":"42","author":"Ye","year":"2022","journal-title":"Chin J. Geron."},{"issue":"35","key":"10.1016\/j.phymed.2025.157707_bib0050","first-page":"55","article-title":"Clinical effect of Xuecetong injection in the treatment of acute cerebral infarction in the elderly and its effect on inflammatory factors and hemorheology","volume":"14","author":"Yu","year":"2021","journal-title":"Chin. J. Clinical Ration Drug Use."},{"issue":"21","key":"10.1016\/j.phymed.2025.157707_bib0051","first-page":"142","article-title":"Study on the effect of alteplase combined with Xuecetong in the treatment of acute ischemic stroke","volume":"19","author":"Yu","year":"2021","journal-title":"Contem Med Forum"},{"issue":"02","key":"10.1016\/j.phymed.2025.157707_bib0052","first-page":"133","article-title":"Xuesaitong injection was clinically observed in 32 cases of acute cerebral infarction","author":"Yuan","year":"2003","journal-title":"J. Emerg Traditional Chin. Med."},{"issue":"12","key":"10.1016\/j.phymed.2025.157707_bib0053","first-page":"88","article-title":"Effects of Xuesaitong injection combined with conventional drugs in treatment of patients with acute cerebral infarction","volume":"36","author":"Zeng","year":"2024","journal-title":"Med J. Chin People's Health."},{"issue":"15","key":"10.1016\/j.phymed.2025.157707_bib0056","first-page":"2230","article-title":"Study on the efficacy of Xuesaitong in the treatment of cerebral infarction and the mechanism of hemorheology","volume":"26","author":"Zhang","year":"2020","journal-title":"Inter Med. Health Guidance News."},{"issue":"16","key":"10.1016\/j.phymed.2025.157707_bib0058","first-page":"3376","article-title":"Effect of Xuesaitong combined with Edaravone on clinical effect and hemodynamics in elderly acute cerebral infarction patients","volume":"40","author":"Zhang","year":"2020","journal-title":"Chin J. Geron."},{"issue":"20","key":"10.1016\/j.phymed.2025.157707_bib0055","first-page":"3789","article-title":"Clinical study of Xuesaitong injection combined with argatroban and clopidogrel in the treatment of acute cerebral infarction","volume":"20","author":"Zhang","year":"2022","journal-title":"Chin J. Integr Med. Cardio-Cerebrovasc Dis."},{"issue":"01","key":"10.1016\/j.phymed.2025.157707_bib0054","first-page":"97","article-title":"Rapid health technology assessment of Xuesaitong injection in the treatment of stroke","volume":"34","author":"Zhang","year":"2023","journal-title":"Chin Pharm"},{"issue":"4","key":"10.1016\/j.phymed.2025.157707_bib0057","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1212\/WNL.0000000000201467","article-title":"Global burden of ischemic stroke in young adults in 204 countries and Territories","volume":"100","author":"Zhang","year":"2023","journal-title":"Neurology."},{"issue":"08","key":"10.1016\/j.phymed.2025.157707_bib0059","first-page":"957","article-title":"Impact of Xuesaitong injection combined with butylphthalide injection on neurological function and four coagulation indicators of patients with acute cerebral infarction","volume":"31","author":"Zhao","year":"2024","journal-title":"Clin. Med. Eng."},{"issue":"07","key":"10.1016\/j.phymed.2025.157707_bib0061","first-page":"938","article-title":"Application progress of hyperbaric oxygen protocol in patients with acute cerebral infarction","volume":"52","author":"Zhao","year":"2023","journal-title":"Shaanxi Med. J"},{"issue":"03","key":"10.1016\/j.phymed.2025.157707_bib0060","article-title":"Effects of Xuesaitong injection combined with Butylphthalide in treatment of patients with acute cerebral infarction","volume":"34","author":"Zhao","year":"2022","journal-title":"Med J. Chin. People's Health."},{"issue":"64","key":"10.1016\/j.phymed.2025.157707_bib0062","first-page":"72","article-title":"Clinical analysis of Xuesaitong in the treatment of ischemic stroke","volume":"15","author":"Zhou","year":"2015","journal-title":"World Latest Med. Inform"},{"issue":"06","key":"10.1016\/j.phymed.2025.157707_bib0064","first-page":"618","article-title":"Effect of Xuesaitong injection combined with butylphthalide on neurological function in patients with acute cerebral infarction","volume":"22","author":"Zhu","year":"2016","journal-title":"Chin J. Thromb Hemost."},{"issue":"7","key":"10.1016\/j.phymed.2025.157707_bib0063","first-page":"106","article-title":"Analysis of the effect of butylphthalide injection combined with Xuesaitong injection in the treatment of cerebral infarction","volume":"16","author":"Zhu","year":"2023","journal-title":"Family pharmacist"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325013418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325013418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T12:19:24Z","timestamp":1768306764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325013418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":64,"alternative-id":["S0944711325013418"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157707","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Xuesaitong injection for acute cerebral infarction: Efficacy and safety meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157707","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"157707"}}